Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

The pox-protein regimen tested in the RV144 trial is the only vaccine strategy demonstrated to prevent HIV-1 infection. Subsequent analyses identified antibody and cellular immune responses as correlates of risk (CoRs) for HIV infection. Early predictors of these CoRs could provide insight into vacc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS Pathog
Asıl Yazarlar: Andersen-Nissen, Erica, Fiore-Gartland, Andrew, Ballweber Fleming, Lamar, Carpp, Lindsay N., Naidoo, Anneta F., Harper, Michael S., Voillet, Valentin, Grunenberg, Nicole, Laher, Fatima, Innes, Craig, Bekker, Linda-Gail, Kublin, James G., Huang, Ying, Ferrari, Guido, Tomaras, Georgia D., Gray, Glenda, Gilbert, Peter B., McElrath, M. Juliana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2021
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7959397/
https://ncbi.nlm.nih.gov/pubmed/33720973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1009363
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller